Form 4 for MASS 908 Devices Inc.
Accepted 2026-09-17 17:27:45 ET · period of report 2026-09-15 · accession 0001836876-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-17 17:27 | 2026-09-15+ | MASS | Kenneweg John | SVP, Sales, Product Marketing | M - OptEx | $0.96 | +27.7K | 63.0K | +78% | +$26.5K |
| DMT | 2026-09-17 17:27 | 2026-09-15+ | MASS | Kenneweg John | SVP, Sales, Product Marketing | S - Sale+OE | $10.13 | -27.7K | 57.8K | -32% | -$280.1K |
| DMT | 2026-09-17 17:27 | 2026-09-15+ | MASS | Kenneweg John | SVP, Sales, Product Marketing | M - OptEx | $0.00 | -27.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-15 | M | A | 1,000 | $0.96 | 58,784 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. |
| 2 | Common | Common Stock | 2026-09-15 | S | D | 1,000 | $10.00 | 57,784 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. |
| 3 | Common | Common Stock | 2026-09-16 | M | A | 21,399 | $0.96 | 79,183 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. |
| 4 | Common | Common Stock | 2026-09-16 | S | D | 21,399 | $10.11 | 57,784 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2026-09-17 | M | A | 5,257 | $0.96 | 63,041 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. |
| 6 | Common | Common Stock | 2026-09-17 | S | D | 5,257 | $10.22 | 57,784 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.13 to $10.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option (right to buy) | 2026-09-15 | M | D | 1,000 | $0.00 | 26,656 | D | $0.96 · — to 2026-12-02 | 1,000 Common Stock | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. (F4) The shares underlying the option are fully vested and immediately exercisable. |
| 8 | Derivative | Stock Option (right to buy) | 2026-09-16 | M | D | 21,399 | $0.00 | 5,257 | D | $0.96 · — to 2026-12-02 | 21,399 Common Stock | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. (F4) The shares underlying the option are fully vested and immediately exercisable. |
| 9 | Derivative | Stock Option (right to buy) | 2026-09-17 | M | D | 5,257 | $0.00 | 0 | D | $0.96 · — to 2026-12-02 | 5,257 Common Stock | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026. (F4) The shares underlying the option are fully vested and immediately exercisable. |